Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Metastatic Castrate-sensitive Prostate Cancer × Androgen Antagonists × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 22 Neoplasm Metastasis 3 Prostate Cancer Metastatic 2 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Hormone Sensitive Prostate Cancer 1 Metastatic Castrate-sensitive Prostate Cancer 1 Genital Diseases, Male 1 Abiraterone Acetate 1

Interventions

apalutamide 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05884398 2026-03-12

LIBERTAS

Janssen Research & Development, LLC

Phase 3 Active not recruiting

Metastatic Castrate-sensitive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡